Comments
Loading...

NovaBay Pharmaceuticals

NBYAMEX
Logo brought to you by Benzinga Data
$0.528700
0.024.93%
At Close: -
15 minutes delayed

NovaBay Pharmaceuticals (AMEX:NBY) Stock, Earnings Estimates, EPS, And Revenue

NovaBay Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 13
EPS
$-1.370
Quarterly Revenue
$2.4M
Annual Revenue
(as of Jun 30)
$13.9M

Analyze the earnings history of NovaBay Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

NovaBay Pharmaceuticals (NBY) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-13$-1.37$-1.23-11.4 %
Mar 20242024-05-09$-4.90$-5.256.67 %
Dec 20232024-03-26$-7.35$-10.5030.0 %
Sep 20232023-11-09$-12.95$-14.007.50 %

NovaBay Pharmaceuticals (NBY) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-13$2.40M$3.15M-23.8 %
Mar 20242024-05-09$2.63M$3.28M-19.8 %
Dec 20232024-03-26$3.73M$3.40M9.62 %
Sep 20232023-11-09$3.27M$3.55M-8.03 %

FAQ

Q

When is NovaBay Pharmaceuticals (AMEX:NBY) reporting earnings?

A

NovaBay Pharmaceuticals (NBY) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for NovaBay Pharmaceuticals (AMEX:NBY)?

A

The Actual EPS was $-1.37, which missed the estimate of $-1.23.

Q

What were NovaBay Pharmaceuticals’s (AMEX:NBY) revenues?

A

The Actual Revenue was $2.4M, which missed the estimate of $3.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch